Aylin Kılıç,
Professor, Refractive and Cataract Surgeon.
In a world where many medical solutions rely on synthetic materials, ophthalmology is witnessing an important shift toward biological and tissue-based approaches.
The cornea itself is primarily composed of collagen, forming a highly organized biological structure responsible for maintaining its transparency and biomechanical stability. For this reason, refractive strategies that utilize collagen-based tissue offer a conceptually elegant and physiologically compatible way to modify corneal shape.
Today, advances in human collagen–based corneal implants and stromal augmentation techniques allow surgeons to reshape the cornea by adding tissue rather than removing it. This represents a meaningful evolution in refractive surgery.
Beyond refractive correction, these approaches also offer promising therapeutic potential in the management of corneal ectatic disorders such as keratoconus, where restoring corneal geometry is critical.
Increasing clinical experience and growing scientific evidence demonstrate that human collagen–based implants:
- Show high biocompatibility.
- Remain structurally stable within the cornea.
- Integrate naturally with the corneal architecture.
As a result, their safety profile and clinical relevance are increasingly supported by scientific data and peer-reviewed literature.
In the coming years, refractive surgery will likely continue evolving beyond purely subtractive procedures toward additive, biologically integrated solutions that work in harmony with the eye’s natural structure.
Collagen-based technologies brings a vital development to shape the future of refractive and corneal surgery.
